58 related articles for article (PubMed ID: 15595432)
1. How do cell-free HIV virions avoid infecting dead-end host cells and cell fragments?
Lyengar S; Schwartz DH
AIDS Rev; 2004; 6(3):155-60. PubMed ID: 15595432
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 infection: is it time to reconsider our concepts?
Krambovitis E; Spandidos DA
Int J Mol Med; 2006 Jul; 18(1):3-8. PubMed ID: 16786149
[TBL] [Abstract][Full Text] [Related]
3. Effects of virion surface gp120 density on infection by HIV-1 and viral production by infected cells.
Bachrach E; Dreja H; Lin YL; Mettling C; Pinet V; Corbeau P; Piechaczyk M
Virology; 2005 Feb; 332(1):418-29. PubMed ID: 15661172
[TBL] [Abstract][Full Text] [Related]
4. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications].
Azevedo-Pereira JM; Santos-Costa Q
Acta Med Port; 2008; 21(5):497-504. PubMed ID: 19187693
[TBL] [Abstract][Full Text] [Related]
5. Dynamic reorganization of chemokine receptors, cholesterol, lipid rafts, and adhesion molecules to sites of CD4 engagement.
Nguyen DH; Giri B; Collins G; Taub DD
Exp Cell Res; 2005 Apr; 304(2):559-69. PubMed ID: 15748900
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of coreceptor-independent cell-to-cell human immunodeficiency virus type 1 transmission by a CD4-immunoglobulin G2 fusion protein.
Bosch B; Blanco J; Pauls E; Clotet-Codina I; Armand-Ugón M; Grigorov B; Muriaux D; Clotet B; Darlix JL; Esté JA
Antimicrob Agents Chemother; 2005 Oct; 49(10):4296-304. PubMed ID: 16189111
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians.
Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S
J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992
[TBL] [Abstract][Full Text] [Related]
8. Be kind to your chemokines.
Gilden D
GMHC Treat Issues; 1996; 10(6/7):28. PubMed ID: 11363642
[TBL] [Abstract][Full Text] [Related]
9. The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling.
Lin YL; Mettling C; Portalès P; Réant B; Robert-Hebmann V; Reynes J; Clot J; Corbeau P
AIDS; 2006 Jun; 20(10):1369-77. PubMed ID: 16791011
[TBL] [Abstract][Full Text] [Related]
10. Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis?
Herbeuval JP; Shearer GM
AIDS Rev; 2006; 8(1):3-8. PubMed ID: 16736946
[TBL] [Abstract][Full Text] [Related]
11. The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion.
Ablan S; Rawat SS; Viard M; Wang JM; Puri A; Blumenthal R
Virol J; 2006 Dec; 3():104. PubMed ID: 17187670
[TBL] [Abstract][Full Text] [Related]
12. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
Désormeaux A; Bergeron MG
Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
[TBL] [Abstract][Full Text] [Related]
13. CXCR4 and CCR5 regulation and expression patterns on T- and monocyte-macrophage cell lineages: implications for susceptibility to infection by HIV-1.
Joly M; Pinto JM
Math Biosci; 2005 May; 195(1):92-126. PubMed ID: 15893340
[TBL] [Abstract][Full Text] [Related]
14. A clathrin-dynamin-dependent endocytic pathway for the uptake of HIV-1 by direct T cell-T cell transmission.
Bosch B; Grigorov B; Senserrich J; Clotet B; Darlix JL; Muriaux D; Este JA
Antiviral Res; 2008 Nov; 80(2):185-93. PubMed ID: 18602423
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the human chemerin receptor--ChemR23/CMKLR1--as co-receptor for human and simian immunodeficiency virus infection, and identification of virus-binding receptor domains.
Mårtensson UE; Fenyö EM; Olde B; Owman C
Virology; 2006 Nov; 355(1):6-17. PubMed ID: 16904155
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy.
Williamson MP; McCormick TG; Nance CL; Shearer WT
J Allergy Clin Immunol; 2006 Dec; 118(6):1369-74. PubMed ID: 17157668
[TBL] [Abstract][Full Text] [Related]
17. Skewed expression and up-regulation of the IL-12 and IL-18 receptors in resting and activated CD4 T cells from HIV-1-infected patients.
de Arquer GR; Peña R; Cabrera C; Coma G; Ruiz-Hernandez R; Guerola R; Clotet B; Ruiz L; Esté JA; Calle ML; Bofill M
J Leukoc Biol; 2007 Jul; 82(1):72-8. PubMed ID: 17403771
[TBL] [Abstract][Full Text] [Related]
18. Control of HIV-1 RNA load after HAART interruption: relationship with CCR5 co-receptor density and proviral DNA load in HIV-infected patients.
Soriano-Sarabia N; Vallejo A; Fernández G; Genebat M; Gutiérrez S; Muñoz-Fernández MA; Leal M
J Clin Virol; 2007 Sep; 40(1):64-7. PubMed ID: 17662650
[TBL] [Abstract][Full Text] [Related]
19. [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].
Theze J
Bull Acad Natl Med; 2008 Oct; 192(7):1453-66; discussion 1466-8. PubMed ID: 19445368
[TBL] [Abstract][Full Text] [Related]
20. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
Swan CH; Bühler B; Steinberger P; Tschan MP; Barbas CF; Torbett BE
Gene Ther; 2006 Oct; 13(20):1480-92. PubMed ID: 16738691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
